This review highlights the current understanding on the pathogenesis, systemic changes with an emphasis on ocular findings, laboratory investigations, and prevention and treatment of this disease.
The pathogenesis, morphological changes and toxicologic features of these cardiomyopathies are described with particular reference to their detection in preclinical toxicity studies.
These observations suggest that a subset of these 117 genes may be mediating asthma pathogenesis through changes in gene regulation, which affect lymphocyte activation.
However, further studies are required on the etiology and pathogenesis of changes involved in this disease to establish an effective treatment modality.
The driving force of such modification is not known but the presence of aberrant base methylation suggests that pathogenesis involves changes to the DNA at the cellular level.
Focusing on those genes highlights the pathogenesis-related changes and allows easy comparison of our data with those in the literature [11], [12], [13], [16], [27], [37].
Over the last decade, the knowledge of cell death signals involved in disease pathogenesis totally changed.
Further analysis is necessary to disclose the mechanism for such dependence but one possible reason is that the role of microglial response in the SCA6 pathogenesis may change as the disease progresses.
It involves the determination of the cause (etiology) of the disease, the understanding of the mechanisms of its development (pathogenesis), the structural changes associated with the disease process (morphological changes), and the functional consequences of these changes.
CLL appears to be similar to other hematologic malignancies whose pathogenesis involves structural changes on the chromosomal level that cause mutational changes on the molecular level, altering important cellular functions, and, ultimately, leading to malignant transformation of a cell (Irons and Stillman 1996).
